SIRPα+ macrophages are increased in patients with FL who progress or relapse after frontline lenalidomide and rituximab
Titel:
SIRPα+ macrophages are increased in patients with FL who progress or relapse after frontline lenalidomide and rituximab
Auteur:
Marques-Piubelli, Mario L. Parra, Edwin R. Feng, Lei Soto, Luisa Solis Gallardo, Mariana Gouni, Sushanth Samaniego, Felipe Noorani, Mansoor Hagemeister, Fredrick B. Westin, Jason R. Lee, Hun Ju Rodriguez, Maria A. Neelapu, Sattva S. Gunther, Jillian R. Fowler, Nathan H. Flowers, Christopher R. Wistuba, Ignacio I. Nastoupil, Loretta J. Vega, Francisco Strati, Paolo